Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026
PRNewswire (Wed, 4-Feb 11:03 AM ET)
BTIG Sticks to Its Buy Rating for Evolent Health (EVH)
TipRanks (Mon, 2-Feb 6:46 AM ET)
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08
PRNewswire (Fri, 2-Jan 4:15 PM ET)
Globe Newswire (Tue, 11-Nov 8:30 AM ET)
PRNewswire (Thu, 6-Nov 4:12 PM ET)
Evolent Announces Third Quarter 2025 Results
PRNewswire (Thu, 6-Nov 4:10 PM ET)
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
Evolent Health Class A trades on the NYSE stock market under the symbol EVH.
As of February 6, 2026, EVH stock price declined to $2.85 with 2,756,012 million shares trading.
EVH has a beta of 0.74, meaning it tends to be less sensitive to market movements. EVH has a correlation of 0.03 to the broad based SPY ETF.
EVH has a market cap of $318.06 million. This is considered a Small Cap stock.
Last quarter Evolent Health Class A reported $480 million in Revenue and $.05 earnings per share. This beat revenue expectation by $9 million and missed earnings estimates by -$.06.
In the last 3 years, EVH traded as high as $36.70 and as low as $2.82.
The top ETF exchange traded funds that EVH belongs to (by Net Assets): VTI, IWM, VB, VXF, VBK.
EVH has underperformed the market in the last year with a price return of -72.5% while the SPY ETF gained +15.5%. EVH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -55.1% and -25.8%, respectively, while the SPY returned +2.2% and +0.2%, respectively.
EVH support price is $2.77 and resistance is $3.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EVH shares will trade within this expected range on the day.